Adverum Biotechnologies, Inc. (ADVM)

NASDAQ: ADVM · IEX Real-Time Price · USD

8.17

-1.31 (-13.82%)

At close: Jul 19, 2024, 4:00 PM

8.21

+0.04 (0.49%)

Pre-market: Jul 22, 2024, 8:59 AM EDT

Adverum Biotechnologies Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2012
Net Income	-112.9	-117.17	-154.54	-145.54	-117.51	-64.49	Upgrade
Depreciation & Amortization	17.16	18.67	10.57	4.65	4.16	1.57	Upgrade
Share-Based Compensation	17.17	17.57	20.08	25.19	20.39	9.9	Upgrade
Other Operating Activities	-13.17	-9.98	15.8	7.87	13.67	3.84	Upgrade
Operating Cash Flow	-91.74	-90.9	-108.09	-107.83	-79.29	-49.17	Upgrade
Capital Expenditures	-0.81	-0.81	-11.82	-15.12	-11.84	-19.25	Upgrade
Change in Investments	54.13	97.68	153.54	93.83	-268.32	-48.83	Upgrade
Investing Cash Flow	53.32	96.88	141.72	78.71	-280.17	-68.07	Upgrade
Share Issuance / Repurchase	120.37	0.49	0.61	2.64	358.09	29.77	Upgrade
Debt Issued / Paid	0	0	0	-0.24	-0.06	-0.11	Upgrade
Other Financing Activities	-0.42	-0.42	-	-	-2.04	-1.47	Upgrade
Financing Cash Flow	119.95	0.07	0.61	2.4	355.99	28.19	Upgrade
Net Cash Flow	81.53	6.04	34.24	-26.73	-3.47	-89.05	Upgrade
Free Cash Flow	-92.55	-91.71	-119.91	-122.95	-91.14	-68.42	Upgrade
Free Cash Flow Margin	-	-2547.50%	-	-1639.39%	-	-27366.80%	Upgrade
Free Cash Flow Per Share	-5.62	-9.10	-12.08	-12.54	-10.70	-10.67	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).